
News|Podcasts|November 10, 2022
An Invitation to Define the Lab of the Future
Author(s)LabVantage Solutions
Today’s labs are not sufficient to handle tomorrow’s challenges. What will labs in 2030 or 2040 look like? Mikael Hagstroem, CEO at LabVantage Solutions and expert in harnessing data and analytics, discusses the three phases of digital transformation needed to reimagine business models, achieve better performance, and create long-term sustainable advantage. It starts with changing our labs – the technologies, processes, ways of working, and data solutions.
Trending on PharmExec
1
Launch is Just the Beginning: Rare Disease Care Requires Durability
2
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
3
Novartis to Layoff 322 NJ Employees: Report
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5




